88255-01-0 |
Purity ≥98%. MW: 420.46 |
100 mg, 500 mg |
MBS132338 |
More Info
|
95343-20-7 |
Purity ≥98%. MW: 664.1 |
100 mg, 500 mg |
MBS130215 |
More Info
|
A 205804 |
Purity ≥98%. MW: 300.39 |
100 mg, 500 mg |
MBS132392 |
More Info
|
A 66 |
Purity ≥98%. MW: 393.52 |
100 mg, 500 mg |
MBS132169 |
More Info
|
A 740003 |
Purity ≥98%. MW: 474.565 |
100 mg, 500 mg |
MBS132187 |
More Info
|
A 740003 |
Purity >98%. A 740003 is a novel competitive antagonist of P2X7 receptors… |
10 mg, 25 mg, 50 mg |
MBS384091 |
More Info
|
A 769662 |
Purity ≥98%. MW: 360.39 |
100 mg, 500 mg |
MBS130892 |
More Info
|
A 769662 |
Purity 97%+. MW: 360.39 |
5 mg, 1ml/10mM (in DMSO), 10 mg |
MBS576261 |
More Info
|
A 803467 |
Purity >98%. A 803467 is a selective blocker of NaV1.8 channels (IC50 valu… |
10 mg, 1 mL (in DMSO), 25 mg |
MBS384093 |
More Info
|
A 83-01 |
Purity ≥98% by HPLC. Background: A selective inhibitor of TGF-beta type… |
1 mg |
MBS842636 |
More Info
|
A 83-01 |
Purity ≥98%. MW: 421.52 |
100 mg, 500 mg |
MBS132328 |
More Info
|
A 83-01 |
Purity >98%. A83-01 is a TGF-β kinase / activin receptor like kinase… |
5 mg, 10 mg, 25 mg |
MBS384095 |
More Info
|
A 922500 |
MW: 428.48 |
5 mg |
MBS8506458 |
More Info
|
A 922500 |
Purity ≥98%. MW: 428.488 |
100 mg, 500 mg |
MBS130245 |
More Info
|
A 967079 |
Purity >98%. A 967079 is a selective TRPA1 channel blocker (IC50 values ar… |
10 mg, 25 mg, 50 mg |
MBS384097 |
More Info
|
A-1155463 |
Purity >98%. A-1155463 is a highly potent and selective BCL-XL inhibitor,… |
5 mg, 10 mg, 50 mg |
MBS384082 |
More Info
|
A-1210477 |
Purity ≥98%. MW: 886.51 |
100 mg, 500 mg |
MBS131280 |
More Info
|
A-1210477 |
Purity ≥99%. MW: 850.04 |
2 mg, 5 mg, 10 mg |
MBS575263 |
More Info
|
A-1210477 |
Purity >98%. A-1210477 is a potent and selective MCL-1 inhibitor. A-121047… |
5 mg, 10 mg, 25 mg |
MBS384084 |
More Info
|
A-1331852 |
Purity ≥98%. MW: 658.82 |
100 mg, 500 mg |
MBS131656 |
More Info
|
A-196 |
Purity ≥99%. A-196 is a potent and selective inhibitor of SUV420 h1 and… |
2 mg, 1ml/10mM (in DMSO), 5 mg |
MBS5750478 |
More Info
|
A-205804 |
Purity 97%+. MW: 300.41 |
5 mg, 10 mg, 1ml/10mM (in DMSO) |
MBS576130 |
More Info
|
A23187 |
Purity >98% by TLC. Background: A calcium ionophore. Causes rapid influx o… |
10 mg |
MBS843148 |
More Info
|
A-366 |
Purity ≥98% by HPLC. Background: A-366 is a potent and selective G9a /… |
1 mg, 5 mg |
MBS842453 |
More Info
|
A-366 |
Purity ≥98%. MW: 329.444 |
100 mg, 500 mg |
MBS131198 |
More Info
|
A-366 |
Purity >98%. A-366 is a potent and selective G9a / GLP histone lysine meth… |
10 mg, 25 mg, 50 mg |
MBS384085 |
More Info
|
A427 |
A427 cells are derived from human lung epithelial carcinoma taken from a 5… |
0.1 mg, 0.2 mg, 0.5 mg |
MBS201043 |
More Info
|
A431 |
A431 cells were established from an epidermoid carcinoma in the skin / epi… |
0.1 mg, 0.2 mg, 0.5 mg |
MBS201022 |
More Info
|
A-443654 |
Purity >98%. A-443654, a specific Akt inhibitor with Ki value of 160 pM, i… |
2 mg, 5 mg, 10 mg |
MBS384086 |
More Info
|
A-484954 |
Purity >98%. A-484954 is a potent, selective inhibitor of eukaryotic longa… |
10 mg, 25 mg, 50 mg |
MBS384087 |
More Info
|
A549 |
A549 cells are adenocarcinomic human alveolar basal epithelial cells. The… |
0.1 mg, 0.2 mg, 0.5 mg |
MBS201023 |
More Info
|
A66 |
MW: 393.53 |
10 mg |
MBS8506193 |
More Info
|
A66 |
Purity >98%. The S-enantiomer of A66 is a potent inhibitor of the p110alph… |
5 mg, 1 mL (in DMSO), 10 mg |
MBS384089 |
More Info
|
A66 |
Purity 97%+. MW: 393.53 |
2 mg, 5 mg, 1ml/10mM (in DMSO) |
MBS575616 |
More Info
|
A-674563 |
MW: 358.44 |
2 mg |
MBS8506244 |
More Info
|
A-674563 |
Purity ≥98%. A-674563 is an Akt1 inhibitor with Ki of 11 nM, modest pot… |
1 mg, 2 mg, 5 mg |
MBS578707 |
More Info
|
A-674563 |
Purity ≥98%. MW: 358.445 |
100 mg, 500 mg |
MBS131746 |
More Info
|
A-674563 |
Purity >98%. A-674563 is a B / Akt inhibitor with an IC50 of 14 nM and als… |
5 mg, 1 mL (in DMSO), 10 mg |
MBS384090 |
More Info
|
A-769662 |
Purity ≥98% by HPLC. Background: Cell-permeable. A potent AMPK activato… |
5 mg |
MBS842018 |
More Info
|
A-769662 |
Purity >98%. A-769662 is a new activator of AMP-activated protein kinase (… |
5 mg, 10 mg, 1 mL (in DMSO) |
MBS384092 |
More Info
|
A77 1726 |
Purity ≥98% by HPLC. Background: Physiologically active metabolite of t… |
5 mg, 25 mg |
MBS842963 |
More Info
|
A77-01 |
Purity ≥98%. MW: 286.33 |
2 mg, 5 mg, 1ml/10mM (in DMSO) |
MBS577536 |
More Info
|
A77-01 |
Purity ≥98%. MW: 286.338 |
100 mg, 500 mg |
MBS130865 |
More Info
|
A-803467 |
Purity ≥98% (TLC). MW: 357.8 |
10 mg, 50 mg |
MBS565381 |
More Info
|
A-803467 |
Purity ≥98% by TLC. Background: A-803467 is a potent, selective inhibit… |
5 mg, 25 mg |
MBS842200 |
More Info
|
A-803467 |
Purity ≥98%. MW: 357.79 |
100 mg, 500 mg |
MBS132100 |
More Info
|
A-803467 |
Purity ≥98%. MW: 357.79 |
1ml/10mM (in DMSO), 10 mg, 25 mg |
MBS575739 |
More Info
|
A-804598 |
Purity >98%. A-804598 is a P2X7 selective, competitive antagonist with the… |
5 mg, 10 mg, 25 mg |
MBS384094 |
More Info
|
A83-01 |
Purity >98% (TLC); NMR (Conforms). ALK inhibitor. Selective glycogen synth… |
5 mg, 25 mg |
MBS515040 |
More Info
|
A-83-01 |
Purity 97%+. MW: 421.52 |
2 mg, 5 mg, 10 mg |
MBS575483 |
More Info
|
A-966492 |
A-966492 is a highly potent and efficacious poly(ADP-ribose) polymerase (P… |
10 mg |
MBS8506196 |
More Info
|
A-966492 |
Purity ≥98%. A-966492 is a novel and potent inhibitor of PARP1 and PARP… |
2 mg, 5 mg, 1ml/10mM (in DMSO) |
MBS578914 |
More Info
|
A-966492 |
Purity ≥98%. MW: 324.359 |
100 mg, 500 mg |
MBS132689 |
More Info
|
A-966492 |
Purity >98%. A-966492 displayed high potency against the poly(ADP-ribose)… |
5 mg, 1 mL (in DMSO), 10 mg |
MBS384096 |
More Info
|
AA26-9 |
MW: 166.18 |
1 mg, 2 mg, 5 mg |
MBS579904 |
More Info
|
A-804598 ?(A 804598; A804598) |
Purity ≥98%. MW: 315.38 |
100 mg |
MBS131368 |
More Info
|
a,a,a',a'-Tetra-(methyl-d3)-5-bromomethyl-1,3-benzenediacetonitrile |
A labeled intermediate in the synthesis of Anastrozole, an aromatase inhib… |
1 mg |
MBS6040319 |
More Info
|
a,a,a',a'-Tetra-(methyl-d3)-5-methyl-1,3-benzenediacetonitrile |
A labeled intermediate in the synthesis of Anastrozole, an aromatase inhib… |
5 mg |
MBS6082065 |
More Info
|
AA (Arachidonic Acid) CLIA Kit |
n/a |
48-strip-wells, 96-strip-wells, 5x96-strip-wells |
MBS2533283 |
More Info
|
AA (Arachidonic Acid) ELISA Kit |
Intended Uses: This ELISA kit applies to the in vitro quantitative determi… |
24-strip-wells, 48-strip-wells, 96-strip-wells |
MBS2513933 |
More Info
|
AA Assay Kit |
n/a |
100 tubes/96 samples |
MBS779792 |
More Info
|
AACOCF3 |
Purity ≥98% (TLC). MW: 356.5 |
10 mg, 50 mg |
MBS565481 |
More Info
|
17-AAG |
Purity ≥98% (TLC). MW: 585.7 |
1 mg |
MBS565664 |
More Info
|
17-AAG |
Purity ≥98% by HPLC. Background: A semi-synthetic derivative of Geldana… |
1 mg, 5 mg |
MBS842762 |
More Info
|
AA,GAB, 1-315aa, Human, His tag, E Coli |
Purity > 90% by SDS-PAGE. AAGAB, also known as P34, may play a role in mem… |
0.1 mg, 0.5 mg |
MBS205316 |
More Info
|
17-AAG (Geldanamycin) |
Purity >99%. MW: 585.69 |
25 mg |
MBS8506254 |
More Info
|
17-AAG (KOS953) |
Purity >98%. 17-AAG is an ansamycin antibiotic which acts as an anti-tumor… |
10 mg, 1 mL (in DMSO), 50 mg |
MBS386264 |
More Info
|
17 AAG (Tanespimyciin) |
Purity ≥98%. MW: 585.698 |
100 mg, 500 mg |
MBS132219 |
More Info
|
17-AAG (Tanespimycin) |
MW: 585.69 |
5 mg, 10 mg, 1ml/10mM (in DMSO) |
MBS5750131 |
More Info
|
AAL-993 |
Purity ≥98% (HPLC). MW: 371.4 |
5 mg, 25 mg |
MBS565421 |
More Info
|
AAL-993 |
Purity ≥98% by TLC. Background: AAL-993 is a potent, selective and cell… |
2 mg, 10 mg |
MBS842171 |
More Info
|
AAL-993 |
Purity ≥98%. MW: 371.363 |
100 mg |
MBS131457 |
More Info
|
AAL-993 |
Purity >98% (TLC: 5% CH3OH / CH2Cl2; Rf=0.46); NMR conforms. VEGF inhibito… |
5 mg, 25 mg |
MBS515037 |
More Info
|
AA,MDC, 1-122aa, Human, His tag, E Coli |
Purity > 90% by SDS-PAGE. AAMDC belongs to the AAMDC family and may play a… |
0.1 mg, 0.5 mg |
MBS205785 |
More Info
|
a-Amylase, Human Pancreatic |
High Purity. MyBioSource produces and manufactures high purity human pancr… |
100 Units, 1000 Units |
MBS170396 |
More Info
|